Then I found Mahmoud ElSohly, a pharmacologist who was working to develop an injectable drug containing urushiol with the ...

By empowering the immune system, he envisions that these hapten-protein complexes will enable the repurposing of cancer drugs for which resistance has emerged. Dr. Lee received his PhD and BS from ...

or protein CD whose culprit is not a low-molecular-weight hapten but a proteinous substance. Clinical Symptoms Symptoms of ICD may include burning, itching, stinging, soreness and pain ...

For indirect labeling, probes are labeled with modified nucleotides that contain a hapten, whereas direct labeling uses nucleotides that have been directly modified to contain a fluorophore.

These reactions generally occur after prior development of an immune response to a hapten–carrier complex. On subsequent encounter with the drug, a hapten–carrier complex is formed again ...

In principle, DOTA-PRIT consists of three sequential administrations of three reagents: (i) the bi-specific Ab construct IgG-scFv (bsAb), which has high specificity and affinity for both a tumor ...

By empowering the immune system, he envisions that these hapten-protein complexes will enable the repurposing of cancer drugs for which resistance has emerged. Dr. Lee received his PhD and BS from ...

This was achieved by linking appropriate hapten groups to nanostructured DNA-protein conjugates 5. Although this initial approach proved feasible, it required elaborate and sophisticated labeling ...

By empowering the immune system, he envisions that these hapten-protein complexes will enable the repurposing of cancer drugs for which resistance has emerged. Dr. Lee received his PhD and BS from the ...